Skip to content

Support Email Service

Technical Support

Tag: Lawsuits

The risk of heart-related issues accompanying the use of JAK inhibitors has brought the entire drug class under scrutiny
Law

The risk of heart-related issues accompanying the use of JAK inhibitors has brought the entire drug class under scrutiny

RobinAugust 20, 2022

Last September, the FDA said it will require safety warnings for drugs such as Pfizer’s Xeljanz, Eli Lilly’s Olumiant and…

Copyright © 2023 Support Email Service | News Center by Ascendoor | Powered by WordPress.